Becker's Healthcare April 5, 2023
Andrew Cass

A pair of Senators have introduced a bill aimed at limiting the alleged abusive pricing practices by pharmacy benefit managers, including the spread pricing technique.

The bill — dubbed the Drug Price Transparency in Medicaid Act of 2023 — would require Medicaid payments to PBMs to be passed directly to pharmacies, excluding administrative fees, according to an April 4 news release from Kansas Sen. Roger Marshall, MD. Dr. Marshall is sponsoring the bill along...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, Regulations
Pharma Dodges The Tariff Bullet — But For How Long?
PBM Private Labeling Boosts Biosimilars, Raises Concerns
Biotech ‘megarounds’ hold steady as startups, VCs wait on IPOs
How BioPharma Can Improve Consumers’ Experience and Health
The Go-To Law Firms For Healthcare and Life Sciences

Share This Article